US FDA grants fast track designation to Kyverna Therapeutics’ KYV─101 to treat lupus nephritis Kyverna Therapeutics (Kyverna), a cell therapy company with the mission of engineering a new class of therapies for...
Latest articles
NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks
NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks The National Institute for Care and Excellence (NICE) has announced that it has recommended an oral treatment for the prevention of episodic...
Objective Platfom is derde partner Nationale Marketing Benchmark
Objective Platfom is derde partner Nationale Marketing Benchmark Objective Platform gaat als derde partner deelnemen aan de Nationale Marketing Benchmark, naast initiatiefnemer Mark Stronger en bestaande partner SRM...
Wat de zorg kan leren van… Marktplaats
Wat de zorg kan leren van… Marktplaats PharmaSwap is een marktplaats voor apothekers om medicatie die anders weggegooid zou worden, verkocht kan worden aan een andere apotheek. Het idee is ontstaan uit de frustratie van...
Bristol Myers Squibb’s NDA accepted by FDA
NDA accepted by FDA Global pharmaceutical company Bristol Myers Squibb (BMS) has announced that its New Drug Application (NDA) has been accepted by the US Food and Drug Administration (FDA) for its ROS1-positive locally...
5 Steps To Better Brainstorming That Works for Your Content Strategy and Audience
5 Steps To Better Brainstorming That Works for Your Content Strategy and Audience Re:Think Innovation author Carla Johnson warns content marketers about brainstorming without doing anything to prime the work. Omitting...
